US Patent Issued to SHANGHAI SIMR BIOTECHNOLOGY, SHANGHAI SIMRD BIOTECHNOLOGY on May 26 for "Substituted [1,2,4triazolo[4,3-bpyridazines as GABA a receptor modulators" (Chinese Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,468, issued on May 26, was assigned to SHANGHAI SIMR BIOTECHNOLOGY Co. LTD. (Shanghai) and SHANGHAI SIMRD BIOTECHNOLOGY Co. LTD. (Shanghai).

"Substituted [1,2,4triazolo[4,3-bpyridazines as GABA a receptor modulators" was invented by Yun Jin (Shanghai), Fei Wang (Shanghai), Jinhua Wu (Shanghai), Nanyang Chen (Shanghai), Yong Sun (Shanghai) and Shuai Li (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a triazolopyridazine derivative, a preparation method therefor, a pharmaceutical composition thereof, and an application thereof. The triazolopyridazine derivative is represented by formula I. The triazolopyridazine derivative has exce...